Literature DB >> 33413418

MicroRNA regulation of cancer stem cells in the pathogenesis of breast cancer.

Tong Niu1,2, Weiwei Zhang1, Wei Xiao3,4.   

Abstract

Breast cancer is the most common cancer among women and accounts for 30% of all female malignancies worldwide. Breast cancer stem cells (BCSCs) are a small population of breast cancer cells that exhibit multiple characteristics including differentiation capacity, self-renewal and therapeutic resistance. Recently, BCSCs have attracted attention due to their modulation of breast tumor behaviors and drug resistance. miRNAs are small noncoding mRNAs involved in virtually all biological processes, including stem cell development, maintenance and differentiation. In breast cancer, miRNAs appear to be multi-faceted since they can act as either suppressors or oncogenes to regulate breast cancer progression. This review summarizes the critical roles of miRNAs in regulating multiple signaling pathways such as Wnt/β-catenin, Notch, PI3K/AKT/mTOR, BMI-1 and STAT3 that are important for the BCSC maintenance.

Entities:  

Keywords:  Breast cancer; Breast cancer stem cell (BCSC); Self-renewal; Therapeutic resistance; miRNA

Year:  2021        PMID: 33413418      PMCID: PMC7792222          DOI: 10.1186/s12935-020-01716-8

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN: 1475-2867            Impact factor:   5.722


  98 in total

1.  A role for microRNAs in maintenance of mouse mammary epithelial progenitor cells.

Authors:  Ingrid Ibarra; Yaniv Erlich; Senthil K Muthuswamy; Ravi Sachidanandam; Gregory J Hannon
Journal:  Genes Dev       Date:  2007-12-15       Impact factor: 11.361

2.  Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

Authors:  Yohei Shimono; Maider Zabala; Robert W Cho; Neethan Lobo; Piero Dalerba; Dalong Qian; Maximilian Diehn; Huiping Liu; Sarita P Panula; Eric Chiao; Frederick M Dirbas; George Somlo; Renee A Reijo Pera; Kaiqin Lao; Michael F Clarke
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

3.  miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.

Authors:  Ivan Bahena-Ocampo; Magali Espinosa; Gisela Ceballos-Cancino; Floria Lizarraga; Denise Campos-Arroyo; Angela Schwarz; Vilma Maldonado; Jorge Melendez-Zajgla; Patricia Garcia‐Lopez
Journal:  EMBO Rep       Date:  2016-04-09       Impact factor: 8.807

Review 4.  Revisiting STAT3 signalling in cancer: new and unexpected biological functions.

Authors:  Hua Yu; Heehyoung Lee; Andreas Herrmann; Ralf Buettner; Richard Jove
Journal:  Nat Rev Cancer       Date:  2014-11       Impact factor: 60.716

5.  miR-99a directly targets the mTOR signalling pathway in breast cancer side population cells.

Authors:  Z Yang; Y Han; K Cheng; G Zhang; X Wang
Journal:  Cell Prolif       Date:  2014-10-27       Impact factor: 6.831

6.  p27-Associated G1 arrest induced by hinokitiol in human malignant melanoma cells is mediated via down-regulation of pRb, Skp2 ubiquitin ligase, and impairment of Cdk2 function.

Authors:  Shicheng Liu; Hitoshi Yamauchi
Journal:  Cancer Lett       Date:  2009-07-23       Impact factor: 8.679

Review 7.  STAT3 inhibitors for cancer therapy: Have all roads been explored?

Authors:  Remi Fagard; Valeri Metelev; Inès Souissi; Fanny Baran-Marszak
Journal:  JAKSTAT       Date:  2013-01-01

8.  CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling.

Authors:  P-K Lo; D Kanojia; X Liu; U P Singh; F G Berger; Q Wang; H Chen
Journal:  Oncogene       Date:  2011-09-26       Impact factor: 9.867

9.  Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN.

Authors:  Mingli Han; Manran Liu; Yimeng Wang; Xin Chen; Jianli Xu; Yan Sun; Liuyang Zhao; Hongbo Qu; Yuanming Fan; Chengyi Wu
Journal:  PLoS One       Date:  2012-06-25       Impact factor: 3.240

10.  miR205 inhibits stem cell renewal in SUM159PT breast cancer cells.

Authors:  Víctor Mayoral-Varo; Annarica Calcabrini; María Pilar Sánchez-Bailón; Jorge Martín-Pérez
Journal:  PLoS One       Date:  2017-11-28       Impact factor: 3.240

View more
  3 in total

Review 1.  Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance.

Authors:  Taniya Saha; Kiven Erique Lukong
Journal:  Front Oncol       Date:  2022-03-21       Impact factor: 6.244

2.  Expression of MiRNA-29b and MiRNA-31 and their diagnostic and prognostic values in Egyptian females with breast cancer.

Authors:  Mona Ahmed Abbas; Ibrahim El Tantawy El Sayed; Azza Mohamed Kamel Abdu-Allah; Abul Kalam; Abdullah G Al-Sehemi; Omar A Al-Hartomy; Maha Salah Abd El-Rahman
Journal:  Noncoding RNA Res       Date:  2022-09-06

3.  Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis.

Authors:  Gang Chen; Mingwei Yu; Jianqiao Cao; Huishan Zhao; Yuanping Dai; Yizi Cong; Guangdong Qiao
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.